Page last updated: 2024-08-24

rubitecan and Breast Cancer

rubitecan has been researched along with Breast Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Z; Giovanella, B; Harris, N; Kozielski, A; Stehlin, JS; Vardeman, D1
Guiney, P; Haney, LG; Lenaz, L; Miller, KD; Murry, DJ; Sledge, GW; Soule, SE; Sun, SL1
Cao, ZS; Dejesus, A; Giovanella, B; Mendoza, J1
Chedid, S; Cristofanilli, M; Esteva, F; Frye, DK; Hortobagyi, G; Ibrahim, N; Mettinger, KL; Rivera, E; Valero, V1
Early, JA; Giovanella, BC; Hinz, HR; Kozielski, AJ; Mendoza, JT; Pantazis, P1
Gilbert, B; Giovanella, BC; Kleinerman, E; Knight, V; Koshkina, N; Waldrep, C1

Trials

2 trial(s) available for rubitecan and Breast Cancer

ArticleYear
A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.
    Investigational new drugs, 2004, Volume: 22, Issue:1

    Topics: Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Camptothecin; Female; Humans; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis

2004
Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.
    Cancer chemotherapy and pharmacology, 2006, Volume: 57, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Disease Progression; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Prospective Studies; Treatment Outcome

2006

Other Studies

4 other study(ies) available for rubitecan and Breast Cancer

ArticleYear
Alkyl esters of camptothecin and 9-nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity.
    Journal of medicinal chemistry, 1998, Jan-01, Volume: 41, Issue:1

    Topics: Acylation; Alkylation; Animals; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Female; Humans; Mice; Mice, Nude; Molecular Structure; Structure-Activity Relationship; Transplantation, Heterologous

1998
Synthesis and anti-tumor activity of alkenyl camptothecin esters.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Esters; Humans; Inhibitory Concentration 50; Mice; Molecular Structure; Neoplasm Transplantation

2005
Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
    Cancer research, 1993, Apr-01, Volume: 53, Issue:7

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Cell Cycle; Cell Division; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; In Vitro Techniques; Mice; Mice, Nude; Tumor Cells, Cultured

1993
Anti-cancer activity of 9-nitrocamptothecin liposome aerosol in mice.
    Transactions of the American Clinical and Climatological Association, 2000, Volume: 111

    Topics: Aerosols; Animals; Antineoplastic Agents; Breast Neoplasms; Camptothecin; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Particle Size; Transplantation, Heterologous

2000